Dendritic cells in NASH: Friend or foe?
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 3
Abstract
Authors and Affiliations
Priya Handa, Kris Kowdley
Keywords
Related Articles
- EP ID EP78293
- DOI -
- Views 117
- Downloads 0
Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome
We retrospectively investigated the characteristics, patterns of disease progression, outcome and difficulties in the management in 11 patients with concurrent autoimmune hepatitis (AIH) and HBV or HCV infections (5 HCV...
Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: Is anti-HCV a risk factor?
Background and Rationale. Among the adverse events related to tuberculosis treatment, hepatotoxicity is the most serious, and recognition of risk factors for it is essential to achieve successful therapy. The aim of the...
Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community
Background. Liver disease continues to be a major cause of morbidity and mortality in sub-Saharan Africa, including Nigeria, due to the high endemicity of viral hepatitis B. However non-alcoholic fatty liver disease may...
Sustained virological response according to the type of early virological response in HCV and HCV/HIV
Background. The most important factors to predict the sustained virological response (SVR) are the genotype and the fibrosis grade, although there are other predictive factors to be considered, mainly in HCV/HIV coinfect...
The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study
Aims. To define the prevalence and clinical characteristics of glucose metabolism disorders (GMD) in patients with compensated liver cirrhosis (LC). Material and methods. Fasting plasma glucose (FPG) levels were measured...